392 related articles for article (PubMed ID: 31093272)
21. Epigenetically regulated microRNAs in Alzheimer's disease.
Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's Disease and ncRNAs.
Maoz R; Garfinkel BP; Soreq H
Adv Exp Med Biol; 2017; 978():337-361. PubMed ID: 28523555
[TBL] [Abstract][Full Text] [Related]
23. FRMD4A-cytohesin signaling modulates the cellular release of tau.
Yan X; Nykänen NP; Brunello CA; Haapasalo A; Hiltunen M; Uronen RL; Huttunen HJ
J Cell Sci; 2016 May; 129(10):2003-15. PubMed ID: 27044754
[TBL] [Abstract][Full Text] [Related]
24. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
Kovacech B; Novak M
Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease.
Ma X; Liu L; Meng J
Neurosci Lett; 2017 Nov; 661():57-62. PubMed ID: 28947385
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
Wang J; Yu JT; Tan MS; Jiang T; Tan L
Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
[TBL] [Abstract][Full Text] [Related]
27. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.
Sharma VK; Mehta V; Singh TG
Curr Neuropharmacol; 2020; 18(8):740-753. PubMed ID: 31989902
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic drugs in Alzheimer's disease.
Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
[TBL] [Abstract][Full Text] [Related]
30. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
31. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
Millan MJ
Dialogues Clin Neurosci; 2014 Sep; 16(3):373-93. PubMed ID: 25364287
[TBL] [Abstract][Full Text] [Related]
32. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's Disease and Histone Code Alterations.
Narayan P; Dragunow M
Adv Exp Med Biol; 2017; 978():321-336. PubMed ID: 28523554
[TBL] [Abstract][Full Text] [Related]
35. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
36. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review).
Li X; Bao X; Wang R
Mol Med Rep; 2016 Aug; 14(2):1043-53. PubMed ID: 27314984
[TBL] [Abstract][Full Text] [Related]
37. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
[TBL] [Abstract][Full Text] [Related]
38. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
Qazi TJ; Quan Z; Mir A; Qing H
Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
[TBL] [Abstract][Full Text] [Related]
39. Cross Talk Between Aluminum and Genetic Susceptibility and Epigenetic Modification in Alzheimer's Disease.
Liang R
Adv Exp Med Biol; 2018; 1091():173-191. PubMed ID: 30315455
[TBL] [Abstract][Full Text] [Related]
40. [Epigenetic mechanisms of Alzheimer's disease and related drug research].
Gong HC; Wang YL; Wang HW
Yao Xue Xue Bao; 2013 Jul; 48(7):1005-13. PubMed ID: 24133967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
